<DOC>
	<DOCNO>NCT02699827</DOCNO>
	<brief_summary>This study aim evaluate effect add magnesium sulphate epidurally adjunct levobupivacaine quality anesthesia perioperative pain relief patient preeclampsia undergoing elective caesarian section ( CS ) .</brief_summary>
	<brief_title>Adding MgSO4 Epidural Levobupivacaine CS Patients With Preeclampsia</brief_title>
	<detailed_description>Pregnant woman preeclampsia undergo elective CS include study . All patient participate study randomly divide two group ; magnesium sulphate group ( study group ) placebo group ( control group ) . Patients study group receive epidural 20 ml levobupivacaine hydrochloride 0.5 % plus 5 ml magnesium sulphate 10 % ( 500 mg ) patient control group receive epidural 20 ml levobupivacaine hydrochloride 0.5 % plus 5 ml saline 0.9 % .</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Levobupivacaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>Pregnant woman preeclampsia undergo elective CS . Age &lt; 20 &gt; 35 year . Height &lt; 150 &gt; 180 cm . Body mass index ( BMI ) &gt; 35 kg/m2 . Active labor . Multifetal pregnancy . Fetal distress . Medical condition complicate pregnancy . HELLP syndrome . Thrombocytopenia . Hepatic renal impairment . Pulmonary edema cyanosis . Placenta previa . Vaginal bleed placental abruption . Contraindication central neuraxial block . History adverse reaction study medication . History analgesic use . Magnesium therapy . Chronic pain syndrome . Presence communication difficulty prevent reliable assessment . Refusal undergo regional anesthesia .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Levobupivacaine</keyword>
	<keyword>Magnesium</keyword>
	<keyword>Preeclampsia</keyword>
	<keyword>Epidural</keyword>
</DOC>